- Report
- April 2024
- 80 Pages
Saudi Arabia
From €1339EUR$1,500USD£1,172GBP
- Report
- April 2024
- 80 Pages
South Korea
From €1339EUR$1,500USD£1,172GBP
From €1339EUR$1,500USD£1,172GBP
- Report
- April 2024
- 80 Pages
United Kingdom
From €1339EUR$1,500USD£1,172GBP
- Report
- April 2024
- 80 Pages
United States
From €1339EUR$1,500USD£1,172GBP
- Report
- July 2024
- 146 Pages
Global
From €3794EUR$4,250USD£3,319GBP
- Report
- March 2024
- 170 Pages
Global
€4459EUR$4,995USD£3,901GBP
- Webinar
- February 2022
- 6 Hours
Europe
From €531EUR$595USD£465GBP
- Training
- 90 Minutes
Europe
- Report
- February 2024
- 93 Pages
Global
From €3500EUR$4,200USD£3,169GBP
- Report
- May 2023
- 110 Pages
Global
From €3500EUR$4,200USD£3,169GBP
The Active Implantable Medical Device (AIMD) market is a subset of the medical device industry that focuses on the development and production of medical devices that are implanted into the body. These devices are designed to monitor, diagnose, and treat a variety of medical conditions. AIMDs are typically powered by batteries and are designed to be implanted for long-term use. Examples of AIMDs include pacemakers, implantable cardioverter defibrillators, neurostimulators, and drug delivery systems.
AIMDs are regulated by the Food and Drug Administration (FDA) and must meet stringent safety and efficacy standards. The market is highly competitive, with a number of large companies competing for market share.
Some of the major players in the AIMD market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and Biotronik. Show Less Read more